LAS VEGAS, July 30, 2014 /PRNewswire/ -- CannaVest Corp.
(OTCBB:CANV), a leading manufacturer and distributor of hemp and
Cannabidiol (CBD) based products, was awarded first place in
the CBD concentrate category at the 2014 Michigan Medical Cannabis Cup, in Clio, Michigan on Sunday, July 27, 2014. CannaVest's
proprietary pharmaceutical grade CBD concentrate, CBD
Simple™, consistently achieves the highest CBD concentration
in the industry, and has won this category in the High Times
Cannabis Cup a record four times. Additionally, CannaVest has been
awarded first place in the 2013 Michigan Green Cup, also in the CBD
Concentrate category.
PlusCBD™ Oil, a consumer grade version of CBD-rich hemp oil, is
exclusively manufactured by CannaVest Laboratories, a division of
CannaVest Corp. in San Diego,
California, under the direction of Dr. Joshua Hartsel, its
lead research scientist. Dr. Hartsel explains how the Company
has been able to achieve its high CBD concentrations. "We spent the
past few years improving on specialized techniques to purify
CBD-rich hemp oil and are currently working on our first patent
submissions in this area. We have been able to achieve the highest
CBD purity levels using our proprietary refining methods. The
lengthy orthogonal purification techniques are complex and have
required years of research to attain the industry's highest CBD
concentrate levels from raw CO2 oil."
CBD is a promising non-psychoactive nutraceutical product
isolated from industrial hemp, and has been recognized for its
pluripotent benefits on human health. PubMed, the online database
of the US National Library of Medicine for the National Institutes
of Health, states that, Cannabidiol (CBD) is a phytocannabinoid
with therapeutic properties for numerous disorders, and is
presently under preclinical research in trials for some specific
diseases. The website notation on CBD cites that, within the
endocannabinoid system, CBD has been shown to have an inhibitory
effect on the inactivation of endocannabinoids, thereby enhancing
the action of these endogenous molecules on cannabinoid receptors,
which is also noted in certain pathological conditions.
CannaVest Laboratories was established to facilitate cutting
edge research on cannabidiol (CBD), and is equipped with state of
the art high-performance equipment and distillation tools to
produce award winning CBD Simple™, and PlusCBD™ Oil.
Additionally, CannaVest is pleased to report the distinction of
adding Dr. Alexandros Makriyannis to lead its Scientific Advisory
Board. Dr. Makriyannis is credited with early discoveries of the
human endocannabinoid system, which has implications for CBD
research and use. Dr. Makriyannis is also the founder of the
Boston-based drug discovery
company, MAKScientific, which specializes in the development and
commercialization of novel therapeutics that modulate the
endocannabinoid system, with advanced preclinical drug candidates.
Dr. Hartsel reports that CannaVest Laboratories will collaborate
directly with Dr. Makriyannis' Boston-based lab and MAKScientific.
Dr. Hartsel, CannaVest Laboratories lead research scientist
concludes, "as we continue to learn more about CBD and its
benefits, I believe this exciting molecule will be embraced as one
of the most important compounds of the century."
About CannaVest
Corp.
CannaVest Corp. (OTCBB:CANV), located in Las Vegas, Nevada, focuses on the procurement
and wholesale of the hemp plant extract cannabidiol (CBD), and the
development, marketing and sale of end consumer products containing
CBD, which is refined into its own PlusCBD Oil™ brand.
CannaVest resells raw industrial hemp product to third parties,
acquired through supply relationships in Europe. Additional information is available
from OTCMarkets.com or by visiting www.cannavest.com.
CannaVest Corp.'s subsidiaries include CannaVest Laboratories
(www.CannaVestLabs.com) that facilitates cutting edge research and
develops nutraceutical and food products, containing cannabidiol
(CBD) oil; and is the developer and manufacturer of CannaVest's own
award winning CBD Simple™. US Hemp Oil,
LLC. (www.USHempOil.com) provides seed procurement, cultivation,
processing, and production consultation; and equipment to support
U.S. farmers, researchers and businesses to cultivate and process
industrial hemp in the US. USHO plans to build seed-processing
mills and bring hemp based products to market.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements
and information, as defined within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, and is subject to the Safe Harbor created by
those sections. This material contains statements about
expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties.
Such forward-looking statements by definition involve risks,
uncertainties and other factors, which may cause the actual
results, performance or achievements of CannaVest Corp. to be
materially different from the statements made herein.
LEGAL DISCLOSURE
CannaVest Corp. does not sell or distribute any products that are
in violation of the United States Controlled Substances Act
(US.CSA). The company does grow, sell and distribute hemp-based
products and are involved with the federally legal distribution of
medical marijuana-based products within certain international
markets.
Corporate Contact:
CannaVest Corp.
2688 S. Rainbow Blvd., Ste. B
Las Vegas, NV 89146
Office: 866-290-2157
Logo -
http://photos.prnewswire.com/prnh/20140403/LA98016LOGO
SOURCE CannaVest Corp.